SCHEMBL6248183

SCHEMBL6248183

CC(=O)Nc1cc(Oc2ccccc2O)c(N)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
HDAC1 Q13547 7/20 0.41
HDAC3 O15379 2/20 0.41
HDAC2 Q92769 2/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NCOR2 Q9Y618 1/20 0.39
KDM4E B2RXH2 1/20 0.39
APOBEC3A P31941 1/20 0.39
GFER P55789 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
NPC1 O15118 2/20 0.39
HDAC6 Q9UBN7 1/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.38
BRD4 O60885 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7600617 0.86 NPSR1 (0.42) CA1CA2CA9HDAC1HDAC3
SCHEMBL6244635 0.85 ESRRA (0.44) CA1CA2CA9HDAC1MEN1
SCHEMBL3250913 0.84 HDAC1 (0.39) CA1CA2CA9HDAC1HDAC3
SCHEMBL3240280 0.82 L3MBTL1 (0.44) HDAC1HDAC3HDAC2MEN1KMT2A
SCHEMBL13841331 0.81 GAA (0.41) HDAC1HDAC3HDAC2MEN1KMT2A
SCHEMBL3241043 0.81 MEN1 (0.46) MEN1KMT2AKDM4EMAPTHTT
SCHEMBL3244227 0.75 ATM (0.42) MEN1KMT2AKDM4ENPC1MAPT
SCHEMBL14639177 0.74 P2RY1 (0.43) MEN1KMT2AKDM4ENPC1MAPT
SCHEMBL6243724 0.73 STK39 (0.43) MEN1KMT2AKDM4ENPC1MAPT
SCHEMBL8955164 0.73 MAPT (0.51) HDAC1MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1276912-C Uracil compounds and use thereof SUMITOMO CHEMICAL CO (JP) 2006-09-27 CN disclosed
EP-1106607-B1 Uracil compounds and their use SUMITOMO CHEMICAL CO (JP) 2005-07-27 EP disclosed
CN-1572786-A Uracil compounds and use thereof SUMITOMO CHEMICAL CO (JP) 2005-02-02 CN disclosed
CN-1187340-C Uracil compound and use thereof SUMITOMO CHEMICAL CO (JP) 2005-02-02 CN disclosed
US-6667413-B2 Aniline derivatives; herbicides; nonphytotoxic SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-12-23 US disclosed
US-20030130124-A1 Herbicides SUMITOMO CHEMICAL COMPANY, LIMITED 2003-07-10 US disclosed
US-6451740-B2 HERBICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-09-17 US disclosed
US-20020013466-A1 Uracil compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-31 US disclosed
CN-1303852-A Uracil compound and use thereof SUMITOMO CHEMICAL CO (JP) 2001-07-18 CN disclosed
EP-1106607-A2 Uracil compounds and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130124-A1 Herbicides CBR3, CBR1, MT-CO1 CA1 1361/4885CA2 285/4885CA9 1838/4885
US-20020013466-A1 Uracil compounds and use thereof UNG, MRM1, OGG1 CA1 2248/4885CA2 1600/4885CA9 2455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.